ReviewLung Cancer (Auckland, N.Z.)2017
Clinical staging of malignant pleural mesothelioma: current perspectives.
Review in Lung Cancer (Auckland, N.Z.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02519049 (Diagnostic and Prognostic Role of 11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma), which is not on this map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Diagnostic and Prognostic Role of 11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM) and Candidate to Pleurodesis
Who cites it
15 citing papers in PubMed.
- Malignant Pleural Mesothelioma (MPM) Evaluation with [Molecular imaging and biology · 2026Observational
- The genetics of cancer heterogeneity and mesothelioma.Frontiers in oncology · 2026Review
- The Accuracy of Video-Assisted Thoracic Surgery Pleural Biopsy in Patients with Suspected Diffuse Pleural Mesothelioma: A Real-Life Study.Journal of clinical medicine · 2025Article
- Prognostic Value of Chest CT Volumetric Analysis in Patients with Malignant Pleural Mesothelioma.Journal of clinical medicine · 2025Article
- Three-dimensional printing of the human lung pleural cavity model for PDT malignant mesothelioma.Photodiagnosis and photodynamic therapy · 2024Article
- Pleural Neoplasms-What Could MRI Change?Cancers · 2023Review
- High Expression ofBioMed research international · 2023Article
- Case Report and Review of Literature: Familial Malignant Pleural Mesothelioma in a 39 Years Old Patient With an InconclusiveFrontiers in surgery · 2022Article
- [Korean Clinical Imaging Guidelines for the Appropriate Use of Chest MRI].Taehan Yongsang Uihakhoe chi · 2021Article
- Surgical staging and resection of malignant pleural mesothelioma.Journal of thoracic disease · 2020Article
- Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population.JTO clinical and research reports · 2020Article
- Diffusion-Weighted Imaging Can Differentiate between Malignant and Benign Pleural Diseases.Cancers · 2019Article
- A case from India of pleural malignant mesothelioma probably due to domestic and environmental asbestos exposure: a posthumous report.BMJ case reports · 2019Article
- Radical aggressive treatment among non-small cell lung cancer patients with malignant pleural effusion without extra-thoracic disease.Journal of thoracic disease · 2019Article
- Staging in the era of international databases: documented improvements with remaining challenges.Journal of thoracic disease · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant pleural mesothelioma (MPM) is a disease with limited therapeutic options, the management of which is still controversial. Diagnosis is usually made by thoracoscopy, which allows multiple biopsies with histological subtyping and is indicated for staging purposes in surgical candidates. The recommended and recently updated classification for clinical use is the TNM staging system established by the International Mesothelioma Interest Group and the International Association for the Study of Lung Cancer, which is based mainly on surgical and pathological variables, as well as on cross-sectional imaging. Contrast-enhanced computed tomography is the primary imaging procedure. Currently, the most used measurement system for MPM is the modified Response Evaluation Criteria in Solid Tumors (RECIST) method, which is based on unidimensional measurements of tumor thickness perpendicular to the chest wall or mediastinum. Magnetic resonance imaging and functional imaging with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.